Download PDF of this Print this section Email this to a friend

notes to the Consolidated financial statementsfor the year ended 30 June 2013

Group        Company 
2013 
R’000 
2012 
 R’000 
      2013 
 R’000 
2012 
 R’000 
     

31. 

Investment in subsidiary 

     
         Investment in subsidiary company       
         Clover SA  326 735  326 735 
         Share-based payment investment in Clover SA  32 881  23 315 
         Total investment in subsidiary  359 616  350 050 
                 

 

Subsidiary and joint venture    Effective interest in capital  Investment in subsidiaries and joint ventures  Profit/(loss) after taxation 
Name of company  Country of incorporation  Nature of business  2013 %  2012 %  2013  R’000  2012  R’000  2013  R’000  2012  R’000 
Clover SA  South Africa  Dairy manufacturing, distribution, sales  100  100  359 616  350 050  99 763  169 298 
Real Juice Co  South Africa  Manufacturing and sales of fruit juices  100  –  174 627  –  22 188  – 
Clover Botswana  Botswana  Dairy manufacturing, distribution, sales  100  100  23 111  23 111  24 940  21 202 
CloverManhattan@  South Africa  Distribution and sales of ice tea  100  50,1  –  3 034  863  1 120 
Clover Swaziland  Swaziland  Distribution and sales of dairy products in Swaziland  100  100  (869) (77)
Lactolab  South Africa  Testing of dairy products  52  52  –  –  2 568  2 087 
Clover Capital  South Africa  Finance  100  100  434 744  91 000  –  – 
Clover Fonterra#   South Africa  Marketing, selling and distribution of dairy and related ingredient products  51  51  3 060  3 060  14 221  12 297 
Clover West Africa  Nigeria  Marketing of non-alcoholic beverage products  100  100  468  468  (9 841) (10 539)
Clover Namibia  Namibia  Distribution and sales of dairy products in Namibia 100  100  –  –  (13) (2 752)
 # Joint venture.
@ In the process of deregistration. 
 
  
Group             Company 
2013 
R’000 
2012 
R’000 
           2013 
R’000 
2012
 R’000 
     

32. 

Share-based payments 

     
        
32.1 
Equity-settled share appreciation rights scheme 
     
       

– Clover Share Appreciation Rights Plan (2010) (ordinary shares in CIL)

On 31 May 2010 the ordinary and preference shareholders approved the Clover Share Appreciation Rights Plan (2010) as well as the placement of 8 million unissued ordinary shares under the control of the Directors to fulfil the Company’s potential future obligations in terms of the plan. The main rules of the scheme are as follows:

The Company’s obligations in terms of this plan can at the election of the Company be settled in cash or by the issue of ordinary shares.

New SAR may be encashed at the election of the participants, at any time after they have vested, provided that the participant concerned is still in the employment of Clover. On encashment employees will be paid an amount equal to the difference between the fair market value of ordinary shares on the date of issue of the new SAR in question and the fair market value of the ordinary shares on the date of encashment.  

Further details on the scheme are available in the detailed circular issued to shareholders on 7 May 2010 and the remuneration report here

The SAR granted are expensed over their vesting period in terms of IFRS 2. The estimated fair value of these SAR was calculated using the Hull-White Trinomial Lattice valuation model. The following inputs were used for the calculation of the fair value: 

Initial allocation – Expected volatility of 30,3%, risk free rate of 8,90% and a dividend yield of 2,34%. 

Second allocation – Expected volatility of 14,9%, risk free rate of 8,90% and a dividend yield of 2,34%. 

Third allocation – Expected volatility of 19,9%, risk free rate of 8,55% and a dividend yield of 3,33%. 

Allocation to new Executive Committee member – Expected volatility of 17,4%, risk free rate of 7,94% and a dividend yield of 2,00%.

Fourth allocation – Expected volatility of 17,4%, risk free rate of 7,94% and a dividend yield of 2,00% 

Allocation to new Executive Committee member – Expected volatility of 23,3%, risk free rate of 7,94% and a dividend yield of 2,18%.

   

 

Share appreciation rights 
Description  Grant date  Weighted average remaining contractual
life (years)
Exercise price  SAR granted
not yet
 exercised 
Estimated weighted average fair value per right at grant date (Adjusted for 2 for 1 share split  Vesting period 
Clover’s Share Appreciation Rights Plan (2010) – Initial allocation   31 May 2010  * Till employment terminates  R4,67  12 676 780
(2012: 15 500 000)
R2,11  One-third on 31 May 2013, a further third on 31 May 2014 and a final third on 31 May 2015 
Clover’s Share Appreciation Rights Plan (2010) –
Second allocation 
18 August 2010  * Till employment terminates   R0,00  933 335
(2012: 1 466 667)
R4,31  One-third on 18 August 2011, a third on 18 August 2012 and final third on 18 August 2013 
Clover’s Share Appreciation Rights Plan (2010) – Third allocation  1 July 2011  Six years  R11,00  1 614 939
(2012: 2 093 918)
R3,11  Full allocation vest on 1 July 2014 
Clover’s Share Appreciation Rights – Allocation to Executive Committee member ER Bosch  1 June 2012  Seven years  R13,50  953 620
(2012: 953 620)
R4,03  One-third on 1 June 2015, one-third on 1 June 2016 and a final third on 1 June 2017 
Clover’s Share Appreciation Rights Plan (2010) – Fourth allocation  1 July 2012  Seven years  R13,73  2 737 742
(2012: Nil)
R3,70  Full allocation vest on 1 July 2015 
Clover’s Share Appreciation Rights Plan (2010) –
Allocation to Executive Committee member MM Palmeiro 
1 October 2012  Seven years  R15,15  925 500
(2012: Nil)
R3,95  One-third on 1 October 2015, a third on 1 October 2016 and a final third on 1 October 2017 
 
Group     Company 
2013 
R’000 
2012 
R’000 
   2013 
R’000 
2012 
R’000 
      Provision against income       
18 407  13 115  Share-based payment reserve       
              

33.

Directors’ remuneration and interests 

 
33.1 Directors’ remuneration 
   2013 
   Basic
salary R’000 
Fees
for
services
as
Director R’000 
Car allow-
ance
R’000 
Individual perfor-
mance
bonus
R’000 
Profit
share bonus   
Retire-
ment and
medical contri­ butions
R’000 
Other benefits* R‘000  Total R’000  Share apprecia-
tion
rights exercised R’000 
Executive Directors                             
JH Vorster  3 778     1 048  1 454  1 615  761  57  8 713  8 498 
HB Roode (retired 30 June 2013) 2 863     816  931  1 034  541  43  6 228  11 967 
LJ Botha  2 587     733  832  925  487  51  5 615  – 
CP Lerm(Dr) 2 240     664  975  696  438  41  5 054  11 852 
Total remuneration of Executive Directors  11 468  –  3 261  4 192  4 270  2 227  192  25 610  32 317 
Non-Executive Directors                            
JAH Bredin (resigned 30 November 2012)    490              499    
HPF du Preez (resigned 30 November 2012)    136              –  136    
WI Büchner      747              –  747    
MG Elliot     272              46  318    
JC Hendriks (Dr)    342              26  368    
TA Wixley     739              –  739    
SF Booysen (Dr)    513              17  530    
NP Mageza     383              –  383    
JNS Du Plessis (Adv)    435              34  469    
NA Smith     272              16  288    
Total remuneration of Non-Executive Directors   –  4 329  –  –  –  –  148  4 477  – 
Total Directors’ remuneration   11 468  4 329  3 261  4 192  4 270  2 227  340  30 087  32 317 
Other Executives (prescribed officers)                           
H Lubbe  2 256     655  975  696  440  55  5 077  9 897 
JHF Botes (Dr) 2 266     657  975  696  441  46  5 081  6 895 
ER Bosch  2 283     629  1 219  580  456  70  5 237  – 
MM Palmeiro (appointed 1 October 2012) 930     264  398  190  172  336  2 290  – 
Total remuneration of other Executives  7 735  –  2 205  3 567  2 162  1 509  507  17 685  16 792 
* Travel and accommodation expenses, fees paid for directorships held in subsidiaries. 
     
   2012 
   Basic
salary R’000 
Fees
for
services
as
Director R’000 
Car
allow-
ance
R’000 
Individual perfor-
mance
bonus
R’000 
Profit
share bonus   
Retire-
ment and
medical contri­ butions
R’000 
Other benefits* R‘000  Total R’000  Share apprecia
- tion
rights exercised R’000 
Executive Directors                            
JH Vorster   3 498     979  2 243  2 020  673  60  9 473  – 
HB Roode  2 651     754  1 482  1 334  462  75  6 758  1 468 
LJ Botha  2 395     672  1 339  1 206  391  48  6 051  1 504 
CP Lerm (Dr) 1 989     581  1 111  1 002  355  198  5 236  489 
Total remuneration of Executive Directors   10 533  –  2 986  6 175  5 562  1 881  381  27 518  3 461 
Non-Executive Directors                            
JAH Bredin     907              20  927    
HPF du Preez      252              255    
WI Büchner      417              –  417    
MG Elliot     252              31  283    
JC Hendriks (Dr)    329              27  356    
TA Wixley     684              –  684    
SF Booysen (Dr)    437              443    
NP Mageza     354              –  354    
JNS Du Plessis (Adv)    431              43  474    
NA Smith     252              14  266    
Total remuneration of Non-Executive Directors   –  4 315  –  –  –  –  144  4 459  – 
Total Directors’ remuneration   10 533  4 315  2 986  6 175  5 562  1 881  525  31 977  3 461 
Other Executives (prescribed officers)                           
H Lubbe  1 882     537  1 052  947  299  52  4 769  489 
JHF Botes (Dr) 1 879     536  1 051  946  300  39  4 751  489 
ER Bosch (appointed 1 June 2012) 190     52        17  265    
Total remuneration of other Executives  3 951  –  1 125  2 103  1 893  616  97  9 785  978 
   
33.2 Interest of Directors and other Executives in share appreciation rights 
The interest of executive and non-executive directors in the shares of the company provided for in the form of share appreciation rights are set out in the table below: 
   Number of rights
as at 30 June
2012 
Share appreciation rights
granted
during
the year 
Number of
right
exercised/ cancelled
during
the year 
Number of rights
as at 30 June
2013 
Share price on
date exercised
Grant
price 
  Date from which exercisable 
JH Vorster   4 587 200         4 587 200     R4,67     One-third on 31 May 2013, a further third on 31 May 2014 and a final third on 31 May 2015. 
   800 000     533 333  266 667  15,93  R0,00     One-third on 18 August 2011, a third on 18 August 2012 and final third on 18 August 2013. 
   821 256        821 256     R11,00    All on 1 July 2014. 
      1 036 716     1 036 716     R13,73    All on 1 July 2015. 
HB Roode   2 616 762      872 254  1 744 508  18,39  R4,67     One-third on 31 May 2013, a further third on 31 May 2014 and a final third on 31 May 2015. 
   266 667         266 667  11,01   R0,00    One-third on 18 August 2011, a third on 18 August 2012 and final third on 18 August 2013. 
   478 979     478 979  –     R11,00    All on 1 July 2014. 
CP Lerm (Dr) 2 454 758      818 253  1 636 505  18,39  R4,67     One-third on 31 May 2013, a further third on 31 May 2014 and a final third on 31 May 2015. 
   88 890      44 445  44 445  14,08  R0,00    One-third on 18 August 2011, a third on 18 August 2012 and final third on 18 August 2013. 
   1 119        1 119     R11,00    All on 1 July 2014. 
      389 123     389 123     R13,73    All on 1 July 2015. 
LJ Botha  2 443 140        2 443 140     R4,67    One-third on 31 May 2013, a further third on 31 May 2014 and a final third on 31 May 2015. 
   266 667        266 667  11,28  R0,00    One-third on 18 August 2011, a third on 18 August 2012 and final third on 18 August 2013. 
   404 063        404 063     R11,00    All on 1 July 2014. 
      533 657     533 657     R13,73    All on 1 July 2015. 
Total Executive Directors   15 229 501  1 959 496  2 747 264  14 441 733            
                         
   Number of rights
as at 30 June 2012  
Share appreciation rights
granted
during
the year  
Number of
right
exercised/ cancelled
during
the year  
Number of rights
as at 30 June 2013 
Share price
on
date exercised  
Grant
price 
  Date from which exercisable 
Other Executives (prescribed officers)                  
H Lubbe   2 027 236      675 745  1 351 491  18,39  R4,67     One-third on 31 May 2013, a further third on 31 May 2014 and a final third on 31 May 2015. 
   88 888     44 444  44 444  14,08  R0     One-third on 18 August 2011, a third on 18 August 2012 and final third on 18 August 2013. 
   57 778        57 778     R11     All on 1 July 2014. 
      389 123     389 123     R13,73    All on 1 July 2015. 
JHF Botes (Dr) 1 370 904      456 968  913 936  18,39  R4,67     One-third on 31 May 2013, a further third on 31 May 2014 and a final third on 31 May 2015. 
   88 888     44 444  44 444  14,08  R0     One-third on 18 August 2011, a third on 18 August 2012 and final third on 18 August 2013. 
   330 723        330 723     R11     All on 1 July 2014. 
      389 123     389 123     R13,73    All on 1 July 2015. 
E Bosch   953 620        953 620     R13,50     One-third on 1 June 2015, a third on 1 June 2016 and final third on 1 June 2017. 
MM Palmeiro     925 500     925 500     15,15    One-third on 1 October 2015, a third on 1 October 2016 and final third on 1 October 2017. 
Total other Executives   4 918 037   1 703 746  1 221 601  5 400 182            
Total   20 147 538  3 663 242  3 968 865  19 841 915            
 
Number of shares at 30 June 2013           Number of shares at 30 June 2012 
Direct   Indirect  Associates           Direct   Indirect   Associates 
           
33.3 
Interest of Directors and other Executives of the Company in ordinary share capital 
        
               Executive Directors          
7 575 496  –  398 315        JH Vorster  7 505 496  –  398 315 
5 346 547  –  –        HB Roode  5 388 276  –  – 
3 919 804  –  –        CP Lerm (Dr) 3 309 341  –  – 
1 887 768  –  –        LJ Botha  2 542 049  –  – 
18 729 615  –  398 315           18 745 162  –  398 315 
               Non-executive Directors           
–  –  –        JAH Bredin
(resigned 30 November 2012)
411 265       
–  480 400  –        WI Büchner*  –  480 400  – 
–  –  –        HPF du Preez*
(resigned 30 November 2012)
64 634  –  – 
241 689  –  –        MG Elliot*  241 689  –  – 
1 112 892  –  –        JC Hendriks (Dr)*  1 112 892  –  – 
–  1 337 586  –        NA Smith  –  1 306 586  – 
47 619  –  –        TA Wixley  47 619  –  – 
1 402 200  1 817 986  –           1 878 099  1 786 986  – 
20 131 815  1 817 986  398 315        Total Directors’ interests in ordinary share capital   20 623 261  1 786 986  398 315 
               Other Executives (prescribed officers)         
771 632  –  –        H Lubbe  523 810  –  – 
738 543  –  –        JHF Botes (Dr) 547 619  –  – 
1 510 175  –  –        Total interest of other Executives in ordinary share capital   1 071 429  –  – 
                 
                          
Number of shares at 30 June 2013           Number of shares at 30 June 2012 
Direct   Indirect  Associates           Direct   Indirect   Associates 
           
33.4 
Interest of Directors and other Executives of the company in preference share capital 
        
               Executive Directors           
–  –  –        JH Vorster   3 696 232  –  – 
–  –  –        HB Roode   1 996 097  –  – 
–  –  –        CP Lerm (Dr) 1 650 385  –  – 
                  7 342 714  –  – 
               Non-executive Directors         
–  –  –        MG Elliot  88 065  –  – 
–  –  –        JC Hendriks (Dr) –  229 885  – 
                  88 065  229 885  – 
–  –  –        Total Directors interests in preference share capital   7 430 779  229 885  – 
               There was no change in the shareholding of Directors in shares of the Company, between the end of the financial year and the approval of the financial statement by the Board on 11 September 2013.         
                          
Group           Company 
2013 
R’000 
2012 
R’000 
         2013 
R’000 
2012 
R’000 
     

34. 

Long-service bonus 

     
        
34.1 
Introduction 
     
            The Group rewards employees with long service by remunerating them with a lump sum after a specific number of service years. Assumptions and valuation methods are as follows:       
        
34.2 
Background 
     
            The long-service bonuses which employees receive differ between employees whose employment date were before 1 January 2001 and employees whose employment date was after 1 January 2001. The benefit is as follows:       
            Employees with an employment date before 1 January 2001       
            Employees receive a bonus of three times their monthly basic salary after 15 years service and one time their monthly basic salary every five years thereafter.       
            Employees with an employment date after 1 January 2001       
            Employees receive a bonus of 10% of their monthly basic salary after 10 years’ service, 15% after 15 years’ service, 20% after 20 years’ service, 25% after 25 years’ service, etc.       
        
34.3 
Valuation method 
     
            The projected unit credit method is used in the calculations. The values of the past service liabilities and the future service liabilities are given separately. The past service liability is the value of the accumulated liability as at the calculation date in respect of service already rendered. The future service liability is the value of the liability from service after the calculation date until the next date the employee is entitled to receive a bonus payment. The total liability is evenly distributed over the period since service inception until the date when the benefit is payable.       
        
34.4 
Valuation results 
     
            Past service liability       
            The total past service liability in respect of long-service bonuses is set out as follows:       
27 884  30 175        Employees with employment date before 01/01/2001       
1 303  983        Employees with employment date after 01/01/2001       
29 187  31 158        Total past service liability       
            The valuation results as at 30 June 2013 are based on best estimate assumptions. The valuation is very sensitive to the real return rate assumed. For every 1% variance in the assumed rate of return, the liability varies by approximately R1 million. The results as at 30 June 2012 are based on the previous best estimates. The figures do not agree with the provisions as per the Group statements as the full liability for the joint venture has been included in the valuation results.       
                    
Group           Company 
2013 
2012 
         2013 
2012 
        
34.5 
Past service liability build-up 
     
            The build-up of the total past service liability for the past year, using the best estimate assumptions are as follows:       
8,9  9,0        a) The following discount rate per annum was used for the calculation of interest cost       
7,7  7,5        b) The following salary escalation rate per annum and merit increases were used       
            c) For current service cost an assumption is made that there are no withdrawals during the financial year       
            d) For benefits paid it is assumed that all benefits were paid as estimated by Clover       
                    
R’000  R’000           R’000  R’000 
            The increase in the past service liability is summarised as follows:       
            Past services liability build-up       
31 158  32 213        Opening balance       
2 685  2 852        Plus: Interest cost       
1 724  1 821           Current service cost       
(9 670) (7 447)       Less: Benefits paid       
3 290  1 719            Actuarial loss       
29 187  31 158        Closing balance       
   

35. Events after the reporting period

On 1 August 2013 Clover SA acquired 70% of Clover Waters. Refer to directors’ report for more detailed information.

Other than the above, no significant events occurred subsequent to the year-end.